Rituximab associated neutropenia: Description of three cases and an insight into the underlying pathogenesis
Open Access
- 1 January 2011
- journal article
- case report
- Published by International Scientific Information, Inc. in Medical Science Monitor
- Vol. 17 (11) , CS133-CS137
Abstract
Background:To describe Rituximab associated neutropenia (RAN), and to explore its underlying mechanism.Case Report:We describe three patients with RAN. The effect of patient’s plasma on colony forming unit, Granulocyte-Monocyte (CFU-GM) was measure...Keywords
This publication has 15 references indexed in Scilit:
- Combined Immunochemotherapy With Reduced Whole-Brain Radiotherapy for Newly Diagnosed Primary CNS LymphomaJournal of Clinical Oncology, 2007
- Late-onset neutropenia following rituximab results from a hematopoietic lineage competition due to an excessive BAFF-induced B-cell recoveryHaematologica, 2007
- A high incidence of late-onset neutropenia following rituximab-containing chemotherapy as a primary treatment of CD20-positive B-cell lymphoma: a single-institution studyAnnals of Oncology, 2006
- Late-Onset Neutropenia in Patients Treated with Rituximab for Non-Hodgkin's LymphomaInternational Journal of Hematology, 2006
- Rituximab-induced acute thrombocytopenia: a report of two cases.2005
- Delayed-Onset Neutropenia in a Patient Receiving Rituximab as Treatment for Refractory Kidney TransplantationTransplantation, 2005
- Delayed‐Onset Grade 4 Neutropenia Associated with Rituximab Therapy in a Patient with Lymphoma: Case Report and Literature ReviewPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2005
- B-cell recovery following rituximab-based therapy is associated with perturbations in stromal derived factor-1 and granulocyte homeostasisBlood, 2005
- Neutropenia in Patients Treated with RituximabNew England Journal of Medicine, 2003
- CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell LymphomaNew England Journal of Medicine, 2002